Figure 3.
(a) Exacerbation of pad lesions after steroid discontinuation; and (b) crusting of lesions with underlying purulent discharge
(a) Exacerbation of pad lesions after steroid discontinuation; and (b) crusting of lesions with underlying purulent discharge